- Home
- ALEC vs OVID Comparison
ALEC vs OVID Comparison
Compare ALEC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- OVID
- Stock Information
- Founded
- ALEC 2013
- OVID 2014
- Country
- ALEC United States
- OVID United States
- Employees
- ALEC N/A
- OVID N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- ALEC Health Care
- OVID Health Care
- Exchange
- ALEC Nasdaq
- OVID Nasdaq
- Market Cap
- ALEC 124.0M
- OVID 117.3M
- IPO Year
- ALEC 2019
- OVID 2017
- Fundamental
- Price
- ALEC $1.27
- OVID $1.27
- Analyst Decision
- ALEC Hold
- OVID Strong Buy
- Analyst Count
- ALEC 9
- OVID 5
- Target Price
- ALEC $3.40
- OVID $3.50
- AVG Volume (30 Days)
- ALEC 3.0M
- OVID 1.4M
- Earning Date
- ALEC 11-06-2025
- OVID 11-12-2025
- Dividend Yield
- ALEC N/A
- OVID N/A
- EPS Growth
- ALEC N/A
- OVID N/A
- EPS
- ALEC N/A
- OVID N/A
- Revenue
- ALEC $69,048,000.00
- OVID $6,610,000.00
- Revenue This Year
- ALEC N/A
- OVID $1,081.80
- Revenue Next Year
- ALEC $314.69
- OVID N/A
- P/E Ratio
- ALEC N/A
- OVID N/A
- Revenue Growth
- ALEC 12.26
- OVID 945.89
- 52 Week Low
- ALEC $0.87
- OVID $0.24
- 52 Week High
- ALEC $4.18
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- ALEC 33.72
- OVID 41.38
- Support Level
- ALEC $1.16
- OVID $1.24
- Resistance Level
- ALEC $1.60
- OVID $1.38
- Average True Range (ATR)
- ALEC 0.13
- OVID 0.11
- MACD
- ALEC 0.03
- OVID -0.01
- Stochastic Oscillator
- ALEC 22.73
- OVID 26.79
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.